C-Jun NH2-Terminal Kinase Contributes to Dexmedetomidine-Induced Contraction in Isolated Rat Aortic Smooth Muscle

被引:17
|
作者
Ok, Seong-Ho [1 ]
Jeong, Young Seok [1 ]
Kim, Jae-Gak [1 ]
Lee, Seung-Min [1 ]
Sung, Hui-Jin [1 ]
Kim, Hye Jung [4 ]
Chang, Ki Churl [4 ]
Kwon, Seong-Chun [5 ]
Sohn, Ju-Tae [1 ,2 ,3 ]
机构
[1] Gyeongsang Natl Univ Hosp, Dept Anesthesiol & Pain Med, Jinju 660702, South Korea
[2] Gyeongsang Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Jinju, South Korea
[3] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea
[4] Gyeongsang Natl Univ, Sch Med, Dept Pharmacol, Jinju, South Korea
[5] Kwandong Univ, Coll Med, Dept Physiol, Kangnung, South Korea
关键词
Dexmedetomidine; mitogen-activated protein kinase; alpha(2B)-adrenoceptors; hypertension; rat aorta; ALPHA(1)-ADRENERGIC ANTAGONIST ACTIONS; DUAL ALPHA(2)-ADRENERGIC AGONIST; LIPOXYGENASE PATHWAY ACTIVATION; NITRIC-OXIDE SYNTHESIS; CORONARY HEMODYNAMICS; CALCIUM; CELLS; HYPERTENSION; MEDETOMIDINE; STIMULATION;
D O I
10.3349/ymj.2011.52.3.420
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Dexmedetomidine, a full agonist of alpha(2B)-adrenoceptors, is used for analgesia and sedation in the intensive care units. Dexmedetomidine produces an initial transient hypertension due to the activation of post-junctional alpha(2B)-adrenoceptors on vascular smooth muscle cells (SMCs). The aims of this in vitro study were to identify mitogen-activated protein kinase (MAPK) isoforms that are primarily involved in full, alpha(2B)-adrenoceptor agonist, dexmedetomidine-induced contraction of isolated rat aortic SMCs. Materials and Methods: Rat thoracic aortic rings without endothelium were isolated and suspended for isometric tension recording. Cumulative dexmedetomidine (10(-9) to 10(-6) M) dose-response curves were generated in the presence or absence of extracellular signal-regulated kinase (ERIC) inhibitor PD 98059, p38 MAPK inhibitor SB 203580, c-Jun NH2-terminal kinase (JNK) inhibitor SP 600125, L-type calcium channel blocker (verapamil and nifedipine), and alpha(2)-adrenoceptor inhibitor atipamezole. Dexmedetomidine-induced phosphorylation of ERIC, JNK, and p38 MAPK in rat aortic SMCs was detected using Western blotting. Results: SP 600125 (10(-6) to 10(-5) M) attenuated dexmedetomidine-evoked contraction in a concentration-dependent manner, whereas PD 98059 had no effect on dexmedetomidine-induced contraction. SB 203580 (10(-5) M) attenuated dexmedetomidine-induced contraction. Dexmedetomidine-evoked contractions were both abolished by atipamezole and attenuated by verapamil and nifedipine. Dexmedetomidine induced phosphorylation of JNK and p38 MAPK in rat aortic SMCs, but did not induce phosphorylation of ERIC. Conclusion: Dexmedetomidine-induced contraction involves a JNK- and p38 MAPK-mediated pathway downstream of alpha(2)-adrenoceptor stimulation in rat aortic SMCs. In addition, dexmedetomidine-induced contractions are primarily dependent on calcium influx via L-type calcium channels.
引用
收藏
页码:420 / 428
页数:9
相关论文
共 50 条
  • [1] Dexmedetomidine-induced contraction involves c-Jun NH2-terminal kinase phosphorylation through activation of the 5-lipoxygenase pathway in the isolated endothelium-denuded rat aorta
    Ok, Seong-Ho
    Byon, Hyo-Jin
    Jin, Hana
    Kim, Hye Jung
    Kim, Woochan
    Nam, In-Koo
    Eun, So Young
    Sohn, Ju-Tae
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2014, 41 (12): : 1014 - 1022
  • [2] c-Jun N-terminal kinase contributes to norepinephrine-induced contraction through phosphorylation of caldesmon in rat aortic smooth muscle
    Lee, YR
    Lee, CK
    Park, HJ
    Kim, H
    Kim, J
    Kim, J
    Lee, KS
    Lee, YL
    Min, KO
    Kim, B
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 (02) : 119 - 125
  • [3] Dexmedetomidine-induced contraction involves tyrosine kinase-mediated calcium sensitization in isolated rat aortae
    Hong, Jeongmin
    Ok, Seong-Ho
    Lee, Soohee
    Kwon, Seongchun
    Subbarao, Raghavendra Baregundi
    Kang, Sebin
    Kim, Jiyoon
    Kim, Jaehwan
    Park, Miyeong
    Sohn, Ju-Tae
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 1597 - +
  • [4] Regulation of Bax by c-Jun NH2-terminal kinase and Bcl-xL in vinblastine-induced apoptosis
    Chu, Rong
    Upreti, Meenakshi
    Ding, Wen-Xing
    Yin, Xiao-Ming
    Chambers, Timothy C.
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (03) : 241 - 248
  • [5] Specific effects of c-Jun NH2-terminal kinase-interacting protein 1 in neuronal axons
    Tang, Shu
    Wen, Qiang
    Zhang, Xiao-jian
    Kan, Quan-cheng
    NEURAL REGENERATION RESEARCH, 2016, 11 (01) : 114 - 118
  • [6] Protein kinase B/Akt activates c-Jun NH2-terminal kinase by increasing NO production in response to shear stress
    Go, YM
    Boo, YC
    Park, H
    Maland, MC
    Patel, R
    Pritchard, KA
    Fujio, Y
    Walsh, K
    Darley-Usmar, V
    Jo, H
    JOURNAL OF APPLIED PHYSIOLOGY, 2001, 91 (04) : 1574 - 1581
  • [7] Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells
    Turner, NA
    Xia, F
    Azhar, G
    Zhang, XM
    Liu, LX
    Wei, JY
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (09) : 1789 - 1801
  • [8] Important role of angiotensin II-mediated c-Jun NH2-terminal kinase activation in cardiac hypertrophy in hypertensive rats
    Izumi, Y
    Kim, S
    Zhan, YM
    Namba, M
    Yasumoto, H
    Iwao, H
    HYPERTENSION, 2000, 36 (04) : 511 - 516
  • [9] Loss of oxidative stress tolerance in hypertension is linked to reduced catalase activity and increased c-Jun NH2-terminal kinase activation
    Gomes, Pedro
    Simao, Sonia
    Lemos, Vera
    Amaral, Joao S.
    Soares-da-Silva, Patricio
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 56 : 112 - 122
  • [10] Deficiency in the c-Jun NH2-terminal kinase signaling pathway confers susceptibility to hyperoxic lung injury in mice
    Morse, D
    Otterbein, LE
    Watkins, S
    Alber, S
    Zhou, ZH
    Flavell, RA
    Davis, RJ
    Choi, AMK
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2003, 285 (01) : L250 - L257